Apps by Putu Angga Risky Raharja
Respiratory COPD Exacerbation app icon

Medical

Respiratory COPD Exacerbation

Putu Angga Risky Raharja

Free No in-app purchases
Open on Apple

About this app

"Respiratory COPD Exacerbation - BAP-65 and DECAF Score" is a mobile app designed to help with health practitioner in assessing the severity and predicting the outcome in acute exacerbation of chronic obstructive pulmonary disease (COPD) by using BAP-65 and DECAF Score. Chronic obstructive pulmonary disease (COPD) is defined as a common preventable and treatable disease, characterised by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. Exacerbations and comorbidities contribute to the overall severity in individual patients. There are several features of "Respiratory COPD Exacerbation - BAP-65 and DECAF Score", namely: - Simple and very easy to use COPD app. - Precise calculation and classification with BAP-65 score. - Easy calculation and interpretation of DECAF score. - Assess severity and predict outcome of acute COPD exacerbation. - It is totally free. Download now! Both BAP-65 and DECAF score in "Respiratory COPD Exacerbation - BAP-65 and DECAF Score" app correlates well with both in-hospital mortality and need for mechanical ventilation in patients with COPD. The BAP-65 system is a score composed of 4 variables. All of them are available upon presentation to the hospital. The B letter stands for Blood Urea Nitrogen (BUN) and it is positive if level is above 25 mg/dL. The A letter stands for Altered Mental Status and it is counted positive when the initial Glasgow Coma Scale (GCS) is 14 or less, or when the physician has designated that the patient was disoriented, stuporous or in coma. The P letter stands for Pulse and it is positive when the initial pulse is above 109 beats/min. Finally, an additional point will be added if the patient was above 65 years old. While DECAF score is a simple, reliable, accurate prediction tool could potentially improve patient care, by identifying patients suitable for hospital discharge or for more intensive therapy / monitoring. DECAF is simple to calculate and apply at the bedside. It requires an assessment of the patient’s usual level of breathlessness and function: the eMRCD score. Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "Respiratory COPD Exacerbation - BAP-65 and DECAF Score" app might be different with your local practice. Consult to expert doctor whenever necessary.

Latest release

What’s New

Version 2.1 May 14, 2021

Fix several bugs and improve performance

Audience growth

Ratings growth

Steady
7-day gain +0
Ratings / day 0.0
30-day gain +0
US rating-count history
0 ratings
0 Sep 8, 2026 · 0 ratings Sep 8, 2026

Baseline captured. Growth appears after the crawler observes a changed rating count.

Momentum comes from crawler snapshots for the tracked storefront. “Viral growth signal” means unusually fast recent rating gains; it is an indicator, not download data.

Price tracking

Price intelligence

1 captured event
Current Free
Historical low Free
Paid → free 0×
Price history
Current Free
Free Sep 8, 2026 · Free Sep 8, 2026

First snapshot captured. The trend line starts after the next crawler price observation.

  1. First observed Sep 8, 2026 · 12:14 AM Free

Screenshots

Respiratory COPD Exacerbation iPhone screenshotRespiratory COPD Exacerbation iPhone screenshotRespiratory COPD Exacerbation iPhone screenshot Respiratory COPD Exacerbation iPad screenshotRespiratory COPD Exacerbation iPad screenshotRespiratory COPD Exacerbation iPad screenshot